Eledon Pharmaceuticals, Inc.
ELDN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$36,184 | -$116,537 | -$87,966 | -$34,506 |
| Dep. & Amort. | $359 | $374 | $373 | $195 |
| Deferred Tax | $431 | $0 | $0 | -$2,354 |
| Stock-Based Comp. | $13,122 | $6,545 | $8,153 | $0 |
| Change in WC | $8,710 | -$4,917 | $2,368 | -$152 |
| Other Non-Cash | -$33,709 | $75,008 | $48,648 | $7,904 |
| Operating Cash Flow | -$47,271 | -$39,527 | -$28,424 | -$28,913 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$156,131 | -$78,287 | $0 | $0 |
| Inv. Sales/Matur. | $85,817 | $33,000 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$70,314 | -$45,287 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $133,307 | $33,017 | $0 | -$449 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $215 | $0 | $0 | $0 |
| Financing Cash Flow | $133,522 | $33,017 | $0 | -$449 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $15,937 | -$51,797 | -$28,424 | -$29,362 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,612 | $56,409 | $84,833 | $114,195 |
| End Cash | $20,549 | $4,612 | $56,409 | $84,833 |
| Free Cash Flow | -$47,271 | -$39,527 | -$28,424 | -$28,913 |